Determination of the in vivo bioavailability of iontophoretically delivered diclofenac using a methyl nicotinate skin inflammation assay

Skin Research and Technology

Volumn 12, Issue 3, 2006, Pages 211-216

  Lambrecht, Renzo ^a   Clarys, Peter ^a   Clijsen, Ron ^b   Barel, André O ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b 'Thim van der Laan'   (Switzerland)

Author keywords

Iontophoresis; Methylnicotinate; Occlusion; Passive diffusion

Indexed keywords

IONTOPHORESIS; METHYLNICOTINATE; OCCLUSION; PASSIVE DIFFUSION;

BIOMEDICAL ENGINEERING; DISEASE CONTROL; DISEASES; EPIDEMIOLOGY; PHYSICAL THERAPY;

SKIN;

DICLOFENAC DIETHYLAMINE; NICOTINIC ACID METHYL ESTER;

ADULT; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INTERMETHOD COMPARISON; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SKIN BLOOD FLOW; SKIN COLOR; SKIN INFLAMMATION; VOLUNTEER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; FEMALE; HUMANS; INFLAMMATION; IONTOPHORESIS; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NICOTINIC ACIDS; SKIN;

EID: 33745627809     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.0909-752X.2006.00161.x     Document Type: Article

References (18)

1. Gudeman SD, Eisele SA, Heidt RS Jr, Colosimo AJ, Stroupe AL. Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone. A randomized, double blind, placebo-controlled study. Am J Sports Med 1997; 25: 312-316.
2. Li LC, Scudds RA, Harth M. The efficacy of dexamethasone iontophoresis for the treatment of rheumatoid arthritic knees: A pilot study. Arthritis Care Res 1996; 9: 126-132.
3. Demirtas RN, Oner C. The treatment of lateral epicondylitis by iontophoresis of sodium salicilate and sodium diclofenac. Clin Rehabil 1998; 12: 23-29.
4. Saggini R, Zoppi M, Vecchiet F, Gatteschi L, Obletter G, Giomberdino MA. Comparison of electromotive drug administration with ketorolac or with placebo in patients with pain from rheumatic disease: A double-masked study. Clin Ther 1996; 18: 1169-1174.
5. Runeson L, Haker E. Iontophoresis with cortisone in the treatment of lateral epicondylalgia (tennis elbow) - a double-blind study. Scan J Med Sci Sports 2002; 12: 136-142.
6. Duteil L, Queille C, Poncet M, Ortonne JP, Czernielewski J. Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation. Clin Exp Dermatol 1990; 15: 195-199.
7. Treffel P, Gabard B. Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay. Skin Pharmacol 1993; 6: 268-275.
8. Johansson J, Lahti A. Topical non-steroidal anti-inflammatory drugs inhibit non-immunologic immediate contact reactions. Contact Dermatitis 1988; 19: 161-165.
9. Poelman MC, Piot B, Guyon F, Deroni M, Lévêque JL. Assessment of topical non-steroidal anti-inflammatory drugs. J Pharm Pharmacol 1989; 41: 720-722.
10. Chan SY, Li Wan Po A. Quantitative evaluation of drug-induced erythema by using a tristimulus colour analyzer: Experimental design and data analysis. Skin Pharmacol 1993; 6: 298-312.
11. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-3232.
12. Treffel P, Gabard B, Bieli E. Relationship between the in-vitro diclofenac epidermal level and the in-vivo anti-inflammatory efficacy of the methylnicotinate test. In: Brain KR, James VJ, Walters KA, eds. Prediction of percutaneous penetration, Vol. 3B. Cardiff, UK: STS Publishing, 1993: 520-527.
13. Treffel P, Gabard B. Ibuprofen epidermal levels after topical application in vitro: Effect of formulation, application time, dose variation and occlusion. Br J Dermatol 1993; 129: 286-291.
14. Lambrecht R, Clarys P, Barel AO. Influence of in vivo iontophoresis on the skin barrier and percutaneous penetration. In: Marks R, Lévêque JL, Voegeli R, eds. Congress proceedings "stratum corneum II". The essential stratum corneum. London, UK: Dunitz Ltd, 2002: 141-149.
15. Turner NG, Kalia YN, Guy RH. The effect of current on skin barrier function in vivo: Recovery kinetics post-iontophoresis. Pharm Res 1997; 14: 1252-1257.
16. Wang Y, Allen LV Jr, Li LC, Tu YH. Iontophoresis of hydrocortisone across hairless mouse skin: Investigation of skin alteration. J Pharm Sci 1993; 82: 1140-1144.
17. Kalia YN, Guy RH. The electrical characteristics of human skin in vivo. Pharm Res 1995; 12: 1605-1613.
18. Lee SH, Choi EH, Feingold KR, Jiang S, Ahn SK. Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment. J Invest Dermatol 1998; 111: 39-43.